Загрузка...
Glycoform and Net Charge Heterogeneity in gp120 Immunogens Used in HIV Vaccine Trials
BACKGROUND: The RV144 clinical trial showed for the first time that vaccination could provide modest but significant protection from HIV-1 infection. To understand the protective response, and to improve upon the vaccine's efficacy, it is important to define the structure of the immunogens used...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3425498/ https://ncbi.nlm.nih.gov/pubmed/22928048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0043903 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|